Skip to main content
Top
Published in: Digestive Diseases and Sciences 11/2010

01-11-2010 | Original Article

The Cannabis Hyperemesis Syndrome Characterized by Persistent Nausea and Vomiting, Abdominal Pain, and Compulsive Bathing Associated with Chronic Marijuana Use: A Report of Eight Cases in the United States

Authors: Maria Soriano-Co, Mihaela Batke, Mitchell S. Cappell

Published in: Digestive Diseases and Sciences | Issue 11/2010

Login to get access

Abstract

Goals/Background

The cannabis hyperemesis syndrome, which is associated with chronic cannabis use, was recently reported in seven case reports and one clinical series of ten patients from Australia. We further characterize this syndrome with eight well-documented cases in the United States and report results of cannabis discontinuation and cannabis rechallenge.

Study Methods

Patients were identified by the three investigators in gastroenterology clinic or inpatient wards at William Beaumont Hospital from January to August 2009 based on chronic cannabis use; otherwise unexplained refractory, recurrent vomiting; and compulsive bathing. Charts were retrospectively analyzed with follow-up data obtained from subsequent physician visits and patient interviews.

Results

The eight patients on average were 32.4 ± 4.1 years old. Five were male. The mean interval between the onset of cannabis use and development of recurrent vomiting was 19.0 ± 3.7 years. Patients had a mean of 7.1 ± 4.3 emergency room visits, 5.0 ± 2.7 clinic visits, and 3.1 ± 1.9 admissions for this syndrome. All patients had visited at least one other hospital in addition to Beaumont Hospital. All patients had vomiting (mean vomiting episodes every 3.0 ± 1.7 h), compulsive bathing (mean = 5.0 ± 2.0 baths or showers/day; mean total bathing time = 5.0 ± 5.1 h/day), and abdominal pain. Seven patients took hot baths or showers, and seven patients experienced polydipsia. Four out of five patients who discontinued cannabis use recovered from the syndrome, while the other three patients who continued cannabis use, despite recommendations for cessation, continued to have this syndrome. Among those four who recovered, one patient had recurrence of vomiting and compulsive bathing with cannabis resumption.

Conclusions

Cannabis hyperemesis is characterized by otherwise unexplained recurrent nausea and vomiting, compulsive bathing, abdominal pain, and polydipsia associated with chronic cannabis use. This syndrome can occur in the United States as well as in Australia. Cannabis cessation may result in complete symptomatic recovery.
Literature
1.
go back to reference Chang YH, Windish D. Cannabinoid hyperemesis relieved by compulsive bathing. Mayo Clin Proc. 2009;84(1):76–78.CrossRefPubMed Chang YH, Windish D. Cannabinoid hyperemesis relieved by compulsive bathing. Mayo Clin Proc. 2009;84(1):76–78.CrossRefPubMed
2.
go back to reference Chepyala P, Olden KW. Cyclic vomiting and compulsive bathing with chronic cannabis abuse. Clin Gastroenterol Hepatol. 2008;6(6):710–712.CrossRefPubMed Chepyala P, Olden KW. Cyclic vomiting and compulsive bathing with chronic cannabis abuse. Clin Gastroenterol Hepatol. 2008;6(6):710–712.CrossRefPubMed
3.
go back to reference Donnino MW, Cocchi MN, Miller J, et al. Cannabinoid hyperemesis: a case series. J Emerg Med; 2009 Sep 16 [Epub ahead of print]. Donnino MW, Cocchi MN, Miller J, et al. Cannabinoid hyperemesis: a case series. J Emerg Med; 2009 Sep 16 [Epub ahead of print].
4.
go back to reference Roche E, Foster PN. Cannabinoid hyperemesis: not just a problem in Adelaide Hills. Gut. 2005;54(5):731.CrossRefPubMed Roche E, Foster PN. Cannabinoid hyperemesis: not just a problem in Adelaide Hills. Gut. 2005;54(5):731.CrossRefPubMed
6.
go back to reference Sontineni SP, Chaudhary S, Sontineni V, et al. Cannabinoid hyperemesis syndrome: clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse. World J Gastroenterol. 2009;15(10):1264–1266.CrossRefPubMed Sontineni SP, Chaudhary S, Sontineni V, et al. Cannabinoid hyperemesis syndrome: clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse. World J Gastroenterol. 2009;15(10):1264–1266.CrossRefPubMed
7.
go back to reference Allen JH, de Moore GM, Heddle R, et al. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis use. Gut. 2004;53(11):1566–1570.CrossRefPubMed Allen JH, de Moore GM, Heddle R, et al. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis use. Gut. 2004;53(11):1566–1570.CrossRefPubMed
8.
go back to reference Compton W, Grant BF, Colliver J, et al. Prevalence of marijuana use disorders in the United States: 1991–1992 and 2001–2002. JAMA. 2004;291(17):2114–2121.CrossRefPubMed Compton W, Grant BF, Colliver J, et al. Prevalence of marijuana use disorders in the United States: 1991–1992 and 2001–2002. JAMA. 2004;291(17):2114–2121.CrossRefPubMed
9.
go back to reference Stinson FS, Ruan WJ, Pickering R, Grant BF. Cannabis use disorders in the USA: prevalence, correlates and co-morbidity. Psychol Med. 2006;36(10):1447–1460.CrossRefPubMed Stinson FS, Ruan WJ, Pickering R, Grant BF. Cannabis use disorders in the USA: prevalence, correlates and co-morbidity. Psychol Med. 2006;36(10):1447–1460.CrossRefPubMed
10.
go back to reference Howlett AC, Barth F, Bonnie TI, et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptor. Pharmacol Rev. 2002;54(2):161–202.CrossRefPubMed Howlett AC, Barth F, Bonnie TI, et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptor. Pharmacol Rev. 2002;54(2):161–202.CrossRefPubMed
12.
go back to reference Vaziri ND, Thomas R, Sterling M, et al. Toxicity with intravenous injection of crude marijuana extract. Clin Toxicol. 1981;18(3):353–366.CrossRefPubMed Vaziri ND, Thomas R, Sterling M, et al. Toxicity with intravenous injection of crude marijuana extract. Clin Toxicol. 1981;18(3):353–366.CrossRefPubMed
13.
go back to reference Boekxstaens GE. Cannabinoid hyperemesis with the unusual symptom of compulsive bathing. Ned Tidjschr Geneeskd. 2005;149(26):1468–1471. Boekxstaens GE. Cannabinoid hyperemesis with the unusual symptom of compulsive bathing. Ned Tidjschr Geneeskd. 2005;149(26):1468–1471.
14.
go back to reference Cappell MS. Colonic toxicity of administered drugs and chemicals. Am J Gastroenterol. 2004;99(6):1175–1190.CrossRefPubMed Cappell MS. Colonic toxicity of administered drugs and chemicals. Am J Gastroenterol. 2004;99(6):1175–1190.CrossRefPubMed
15.
go back to reference Devane WA, Hanus L, Breuer A, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992;258(5090):1946–1949.CrossRefPubMed Devane WA, Hanus L, Breuer A, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992;258(5090):1946–1949.CrossRefPubMed
16.
go back to reference Duncan M, Davison JS, Sharkey KA. Review article: endocannabinoids and their receptors in the enteric nervous system. Aliment Pharmacol Ther. 2005;22(8):667–683.CrossRefPubMed Duncan M, Davison JS, Sharkey KA. Review article: endocannabinoids and their receptors in the enteric nervous system. Aliment Pharmacol Ther. 2005;22(8):667–683.CrossRefPubMed
17.
go back to reference Wallace D, Martin AL, Park B. Cannabinoid hyperemesis: marijuana puts patients in hot water. Aust Psychiatry. 2007;15(2):156–158.CrossRef Wallace D, Martin AL, Park B. Cannabinoid hyperemesis: marijuana puts patients in hot water. Aust Psychiatry. 2007;15(2):156–158.CrossRef
18.
go back to reference Ashton CH. Adverse effects of cannabis and cannabinoids. Br J Anaesth. 1999;83(4):637–649.PubMed Ashton CH. Adverse effects of cannabis and cannabinoids. Br J Anaesth. 1999;83(4):637–649.PubMed
19.
go back to reference Cota D, Steiner M, Marsicano G, et al. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. Endocrinology. 2007;148(4):1574–1581.CrossRefPubMed Cota D, Steiner M, Marsicano G, et al. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. Endocrinology. 2007;148(4):1574–1581.CrossRefPubMed
20.
go back to reference McCallum RW, Soykan I, Sridhar KR, et al. Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study. Aliment Pharmacol Ther. 1999;13(1):77–80.CrossRefPubMed McCallum RW, Soykan I, Sridhar KR, et al. Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study. Aliment Pharmacol Ther. 1999;13(1):77–80.CrossRefPubMed
21.
go back to reference Davis M, Maida V, Daeninck P, et al. The emerging role of cannabinoid neuromodulators in symptom management. Support Care Cancer. 2007;15(1):63–71.CrossRefPubMed Davis M, Maida V, Daeninck P, et al. The emerging role of cannabinoid neuromodulators in symptom management. Support Care Cancer. 2007;15(1):63–71.CrossRefPubMed
22.
go back to reference Degenhardt L, Hall WD. The adverse effects of cannabinoids: implications for use of medical marijuana. CMAJ. 2008;178(13):1685–1686.PubMed Degenhardt L, Hall WD. The adverse effects of cannabinoids: implications for use of medical marijuana. CMAJ. 2008;178(13):1685–1686.PubMed
24.
go back to reference Pagotto U, Marsicano G, Fezza F, et al. Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level. J Clin Endocrinol Metab. 2001;86(6):2687–2696.CrossRefPubMed Pagotto U, Marsicano G, Fezza F, et al. Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level. J Clin Endocrinol Metab. 2001;86(6):2687–2696.CrossRefPubMed
25.
go back to reference Budney AJ, Roffman R, Stephens RS, et al. Marijuana dependence and its treatment. Addict Sci Clin Pract. 2007;4(1):16–18.CrossRef Budney AJ, Roffman R, Stephens RS, et al. Marijuana dependence and its treatment. Addict Sci Clin Pract. 2007;4(1):16–18.CrossRef
26.
go back to reference Pagotto U, Marsicano G, Cota D, et al. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev. 2006;27(1):73–100.CrossRefPubMed Pagotto U, Marsicano G, Cota D, et al. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev. 2006;27(1):73–100.CrossRefPubMed
27.
go back to reference Abell TL, Adams KA, Boles RG, et al. Cyclic vomiting syndrome in adults. Neurogastroenterol Motil. 2008;20(4):269–284.CrossRefPubMed Abell TL, Adams KA, Boles RG, et al. Cyclic vomiting syndrome in adults. Neurogastroenterol Motil. 2008;20(4):269–284.CrossRefPubMed
28.
go back to reference Pareek N, Fleisher DR, Abell T. Cyclic vomiting syndrome: what a gastroenterologist needs to know. Am J Gastroenterol. 2007;102(12):2832–2840.CrossRefPubMed Pareek N, Fleisher DR, Abell T. Cyclic vomiting syndrome: what a gastroenterologist needs to know. Am J Gastroenterol. 2007;102(12):2832–2840.CrossRefPubMed
29.
go back to reference Forbes D, Withers B, Silburn S, et al. Psychological and social characteristics and precipitants of vomiting in children with cyclical vomiting syndrome. Dig Dis Sci. 1999;44(8):19–22. Forbes D, Withers B, Silburn S, et al. Psychological and social characteristics and precipitants of vomiting in children with cyclical vomiting syndrome. Dig Dis Sci. 1999;44(8):19–22.
30.
31.
go back to reference Stickler GB. Relationship between cyclic vomiting syndrome and migraine. Clin Pediatr. 2005;44(6):505–508.CrossRef Stickler GB. Relationship between cyclic vomiting syndrome and migraine. Clin Pediatr. 2005;44(6):505–508.CrossRef
Metadata
Title
The Cannabis Hyperemesis Syndrome Characterized by Persistent Nausea and Vomiting, Abdominal Pain, and Compulsive Bathing Associated with Chronic Marijuana Use: A Report of Eight Cases in the United States
Authors
Maria Soriano-Co
Mihaela Batke
Mitchell S. Cappell
Publication date
01-11-2010
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2010
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1131-7

Other articles of this Issue 11/2010

Digestive Diseases and Sciences 11/2010 Go to the issue